Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Peripheral

Explore clinical trials studying Lymphoma, T-Cell, Peripheral. Study availability and eligibility vary by location and protocol.

235 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Peripheral trial results

Completed

Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

NCT04101331

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center) Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Los Angeles (UCLA) Health Los Angeles, California, United States
  • Emory University Clinic/Winship Cancer Institute Atlanta, Georgia, United States
View all 69 locations
View Trial Details
Completed

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms

NCT03493451

Conditions
ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
Locations
  • British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 24 locations
View Trial Details
Completed

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

NCT05140382

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Hackensack, New Jersey, United States
  • Research Site Houston, Texas, United States
View all 27 locations
View Trial Details
Completed

Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy

NCT02464228

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)

NCT01716806

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of South Alabama - Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
View all 54 locations
View Trial Details
Completed

Minimal Residual Disease in Peripheral T-cell Lymphoma

NCT03297697

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions